FYSIODANMARK ApS

 

Quicksearch
from your own companies




Analyst: XBRLDenmark
 
Loading...

Loading...

Loading...

Loading...

 
Loading...

Bankruptcy Risk 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
Bankruptcy risk for industry  1.5% 1.5% 1.5% 1.5% 1.5%  
Bankruptcy risk  8.5% 4.6% 3.0% 2.3% 2.2%  
Credit score (0-100)  29 44 57 63 66  
Credit rating  BB BBB BBB BBB BBB  
Credit limit (kDKK)  0.0 0.0 0.0 0.1 0.3  

How are these values calculated?
 
View the automatically generated explanation of bankruptcy risk

Income statement (kDKK) 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12

Net sales  0 0 0 0 0  
Gross profit  3,871 4,532 4,781 5,098 4,253  
EBITDA  1,125 2,219 2,425 2,793 1,430  
EBIT  184 1,111 1,474 2,327 1,116  
Pre-tax profit (PTP)  61.4 1,059.7 1,448.9 2,359.3 1,139.7  
Net earnings  23.8 817.3 1,127.6 1,837.2 883.2  
Pre-tax profit without non-rec. items  61.4 1,060 1,449 2,359 1,140  

 
See the entire income statement

Balance sheet (kDKK) 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12

Tangible assets total  0.0 15.7 8.7 29.8 12.9  
Shareholders equity total  1,066 1,969 3,134 5,043 5,991  
Interest-bearing liabilities  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  3,640 5,023 4,344 6,736 7,258  

Net Debt  -684 -2,178 -2,529 -4,795 -4,605  
 
See the entire balance sheet

Volume 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12

Net sales  0 0 0 0 0  
Net sales growth  0.0% 0.0% 0.0% 0.0% 0.0%  
Gross profit  3,871 4,532 4,781 5,098 4,253  
Gross profit growth  60.3% 17.1% 5.5% 6.6% -16.6%  
Employees  4 3 3 3 4  
Employee growth %  33.3% -25.0% 0.0% 0.0% 33.3%  
Employee expenses  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  3,640 5,023 4,344 6,736 7,258  
Balance sheet change%  67.3% 38.0% -13.5% 55.1% 7.7%  
Added value  1,125.4 2,219.0 2,424.7 3,278.3 1,429.6  
Added value %  0.0% 0.0% 0.0% 0.0% 0.0%  
Investments  -434 -1,699 -1,587 -715 -269  

Net sales trend  0.0 0.0 0.0 0.0 0.0  
EBIT trend  1.0 2.0 3.0 4.0 5.0  

Profitability 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
EBITDA %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT to gross profit (%)  4.7% 24.5% 30.8% 45.6% 26.2%  
Net Earnings %  0.0% 0.0% 0.0% 0.0% 0.0%  
Profit before depreciation and extraordinary items %  0.0% 0.0% 0.0% 0.0% 0.0%  
Pre tax profit less extraordinaries %  0.0% 0.0% 0.0% 0.0% 0.0%  
ROA %  2.6% 24.8% 31.5% 42.7% 16.6%  
ROI %  4.6% 48.6% 53.3% 56.3% 20.4%  
ROE %  2.3% 53.9% 44.2% 44.9% 16.0%  

Solidity 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
Equity ratio %  29.3% 39.2% 72.1% 76.0% 82.5%  
Relative indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Relative net indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net int. bear. debt to EBITDA, %  -60.8% -98.2% -104.3% -171.7% -322.1%  
Gearing %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net interest  0 0 0 0 0  
Financing costs %  81.4% 0.0% 0.0% 0.0% 0.0%  

Liquidity 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
Quick Ratio  1.1 1.3 3.4 4.2 6.7  
Current Ratio  1.1 1.3 3.4 3.9 6.7  
Cash and cash equivalent  684.1 2,178.4 2,529.2 4,795.2 4,605.2  

Capital use efficiency 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
Trade debtors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Trade creditors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Current assets / Net sales %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net working capital  197.4 878.3 2,608.4 4,679.0 5,744.2  
Net working capital %  0.0% 0.0% 0.0% 0.0% 0.0%  

Employee efficiency 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
Net sales / employee  0 0 0 0 0  
Added value / employee  281 740 808 1,093 357  
Employee expenses / employee  0 0 0 0 0  
EBITDA / employee  281 740 808 931 357  
EBIT / employee  46 370 491 776 279  
Net earnings / employee  6 272 376 612 221